Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease

Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease

Crohn’s disease (CD) is a relapsing and progressive condition characterized by diarrhea, abdominal pain, weight loss, and hematochezia that results in serious complications such as perforations, fistulas, and abscesses. Various medications, interventions, and surgical treatments have been used to tr...

Full description

Bibliographic Details
Main Authors: Seong-Joon Koh, Sung Noh Hong, Soo-Kyung Park, Byong Duk Ye, Kyeong Ok Kim, Jeong Eun Shin, Yong Sik Yoon, Hong Sub Lee, Sung Hoon Jung, Miyoung Choi, Soo-Young Na, Chang Hwan Choi, Joo Sung Kim
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2023-01-01
Series:Intestinal Research
Subjects:
crohn disease
guideline
biologics
biosimilars
Online Access:http://www.irjournal.org/upload/pdf/ir-2022-00029.pdf

Internet

http://www.irjournal.org/upload/pdf/ir-2022-00029.pdf

Similar Items